China News
-
Sanjiu Medical keeps focus on R&D
China | Analysis | By BioSpectrum Bureau | 0 Comment | 21 Jun, 2012
Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...Read more
-
GSK executives confessed to bribery charges: China
China | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013
Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's se...Read more
-
J&J puts all Chinese units under single local chairman
China | News | By BioSpectrum Bureau | 0 Comment | 29 Aug, 2013
Singapore: The business heads of Johnson & Johnson's (J&J) three Chinese operations would report to one local ch...Read more
-
China develops revolutionary TCM migraine medication
China | News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2012
Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine ta...Read more
-
Can-Fite APIs to be manufactured by China CRO
China | News | By BioSpectrum Bureau | 0 Comment | 24 Jan, 2013
Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF1...Read more
-
X-Change to launch Phytiva in China, SE Asia
China | News | By BioSpectrum Bureau | 0 Comment | 28 Jan, 2013
Singapore: X-Change, a US-based boutique company whose niche is extract-based cosmeceutical and nutraceutical solutions ...Read more
-
OrbusNeich launches dual therapy heart stent
China | News | By BioSpectrum Bureau | 0 Comment | 29 May, 2013
Singapore: Hong Kong-based OrbusNeich has launched dual therapy stent to address the challenges of delayed healing of th...Read more
-
China vitamin C manufacturer fined by US court
China | News | By BioSpectrum Bureau | 0 Comment | 20 Mar, 2013
Singapore: A US court has fined North China Pharmaceutical (NCPC), a vitamin C manufacturer and antibiotics supplier, $1...Read more
-
Daewoong buys China's Liaoning Baifeng for $20 mn
China | News | By BioSpectrum Bureau | 0 Comment | 06 Aug, 2013
Singapore: Daewoong Pharmaceutical is going to acquire Liaoning Baifeng, a Shenyang (Liaoning Province)-based manufactur...Read more
-
Charles River grows $286 mn in Q1 2013
China | Company results | By BioSpectrum Bureau | 0 Comment | 02 May, 2013
Singapore: Charles River Laboratories has reported an increase of 1.8 percent in first quarter of 2013, clocking $286.0 ...Read more
-
Shenzhen Accord all set to go beyond China
China | Analysis | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012
China is undergoing healthcare reforms and, in the process, industry regulations are becoming strict. Adopting a new bus...Read more
-
India, China top 2013's GMP failures: EMA
China | News | By BioSpectrum Bureau | 0 Comment | 09 Jan, 2014
Singapore: In a bid to bring about transparency, the European Medicines Agency (EMA) has released the public version of ...Read more
-
Dehaier reports decrease in revenue in Q3'12
China | Company results | By BioSpectrum Bureau | 4 Comment | 15 Nov, 2012
Singapore: Dehaier Medical Systems, an emerging leader in the development, assembly, marketing and sale of medical devic...Read more
-
MedImmune, WuXi form joint venture
China | News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012
Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a research and development outsourcing c...Read more
-
HUYA, Sanzao Park partner for drug development
China | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partne...Read more
-
Baird Capital invests in Kedu Healthcare in China
China | News | By BioSpectrum Bureau | 0 Comment | 28 Aug, 2013
Singapore: Investment firm Baird Capital has invested in Kedu Healthcare, one of China's largest independent medical equ...Read more
-
Police: Sexual favours spurred GSK's $1.5 bn China sales
China | News | By BioSpectrum Bureau | 0 Comment | 16 Jul, 2013
Singapore: A day after making the allegations against GlaxoSmithKline's senior executives public, China's Public Securit...Read more
-
Asia bags $6.6 bn M&A deals in 2013
China | Analysis | By BioSpectrum Bureau | 0 Comment | 28 Mar, 2014
Singapore: The Asia-Pacific (APAC) region attracted around 101 M&A deals in pharma, medical, and biotech industry in...Read more
